Typical platelet LTA tracings with different agonists in a healthy subject, a patient with a primary PFD, and a subject after aspirin (ASA) intake. The table shows the percentages of maximal aggregation to each agonist and the percentages of 14C-5-HT secretion of the same patients, respectively.